ProfileGDS5678 / 1423238_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 28% 51% 17% 17% 17% 17% 17% 17% 17% 17% 17% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4297217
GSM967853U87-EV human glioblastoma xenograft - Control 22.6298928
GSM967854U87-EV human glioblastoma xenograft - Control 33.2228551
GSM967855U87-EV human glioblastoma xenograft - Control 42.368917
GSM967856U87-EV human glioblastoma xenograft - Control 52.3691817
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4624217
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4490317
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4032917
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3897217
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4117217
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4131617
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3936717
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4377418
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4202818